AAAAAA
Results: 1-25/62
Authors:
GEISLER J
KING N
ANKER G
ORNATI G
DISALLE E
LONNING PE
DOWSETT M
Citation: J. Geisler et al., IN-VIVO INHIBITION OF AROMATIZATION BY EXEMESTANE, A NOVEL IRREVERSIBLE AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Clinical cancer research, 4(9), 1998, pp. 2089-2093
Authors:
GEISLER J
GEISLER SB
LONNING PE
SMAALAND R
TVEIT KM
REFSUM H
UELAND PM
Citation: J. Geisler et al., CHANGES IN FOLATE STATUS AS DETERMINED BY REDUCTION IN TOTAL PLASMA HOMOCYSTEINE LEVELS DURING LEUCOVORIN MODULATION OF 5-FLUOROURACIL THERAPY IN CANCER-PATIENTS, Clinical cancer research, 4(9), 1998, pp. 2125-2128
Authors:
HELLE SI
JONAT W
GIURESCU M
EKSE D
HOLLY JMP
LONNING PE
Citation: Si. Helle et al., INFLUENCE OF TREATMENT WITH ONAPRISTONE ON THE IGF-SYSTEM IN BREAST-CANCER PATIENTS, Journal of steroid biochemistry and molecular biology, 66(3), 1998, pp. 159-163
Authors:
HELLE SI
ANKER GB
MEADOWS KA
HOLLY JMP
LONNING PE
Citation: Si. Helle et al., ALTERATIONS IN THE INSULIN-LIKE-GROWTH-FACTOR SYSTEM DURING THE MENSTRUAL-CYCLE IN NORMAL WOMEN, Maturitas, 28(3), 1998, pp. 259-265
Authors:
BERNTSEN H
LONNING PE
EKSE D
NETTELAND B
JOHANNESSEN DC
BERGE R
SVARDAL A
Citation: H. Berntsen et al., INFLUENCE OF TREATMENT WITH AMINOGLUTETHIMIDE ON PLASMA AND RED-BLOOD-CELL GLUTATHIONE STATUS IN BREAST-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 46-52
Authors:
HAARSTAD H
LONNING PE
GUNDERSEN S
WIST E
RAABE N
KVINNSLAND S
Citation: H. Haarstad et al., INFLUENCE OF DROLOXIFENE ON METASTATIC BREAST-CANCER AS FIRST-LINE ENDOCRINE TREATMENT, Acta oncologica, 37(4), 1998, pp. 365-368
Authors:
LONNING PE
Citation: Pe. Lonning, PHARMACOLOGICAL PROFILES OF EXEMESTANE AND FORMESTANE, STEROIDAL AROMATASE INHIBITORS USED FOR TREATMENT OF POSTMENOPAUSAL BREAST-CANCER, Breast cancer research and treatment, 49, 1998, pp. 45-52
Authors:
LONNING PE
GEISLER J
DOWSETT M
Citation: Pe. Lonning et al., PHARMACOLOGICAL AND CLINICAL PROFILE OF ANASTROZOLE, Breast cancer research and treatment, 49, 1998, pp. 53-57
Authors:
ANKER GB
LONNING PE
AAKVAAG A
LIEN EA
Citation: Gb. Anker et al., THYROID-FUNCTION IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH TAMOXIFEN, Scandinavian journal of clinical & laboratory investigation, 58(2), 1998, pp. 103-107
Authors:
GEISLER P
LUNDGREN S
BERNTSEN H
GREAVES JL
LONNING PE
Citation: P. Geisler et al., INFLUENCE OF DEXAMINOGLUTETHIMIDE, AN OPTICAL ISOMER OF AMINOGLUTETHIMIDE, ON THE DISPOSITION OF ESTRONE SULFATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, The Journal of clinical endocrinology and metabolism, 83(8), 1998, pp. 2687-2693
Authors:
GUTTORMSEN AB
UELAND PM
LONNING PE
MELLA O
REFSUM H
Citation: Ab. Guttormsen et al., KINETICS OF PLASMA TOTAL HOMOCYSTEINE IN PATIENTS RECEIVING HIGH-DOSEMETHOTREXATE THERAPY, Clinical chemistry, 44(9), 1998, pp. 1987-1989
Authors:
LONNING PE
Citation: Pe. Lonning, AROMATASE INHIBITORS AND THEIR FUTURE-ROLE IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 12-15
Authors:
HELLE SI
GEISLER J
POULSEN JP
HESTDAL K
MEADOWS K
COLLINS W
TVEIT KM
VISTE A
HOLLY JMP
LONNING PE
Citation: Si. Helle et al., MICROENCAPSULATED OCTREOTIDE PAMOATE IN ADVANCED GASTROINTESTINAL ANDPANCREATIC-CANCER - A PHASE-I STUDY, British Journal of Cancer, 78(1), 1998, pp. 14-20
Authors:
JOHANNESSEN DC
ENGAN T
DISALLE E
ZURLO MG
PAOLINI J
ORNATI G
PISCITELLI G
KVINNSLAND S
LONNING PE
Citation: Dc. Johannessen et al., ENDOCRINE AND CLINICAL EFFECTS OF EXEMESTANE (PNU-155971), A NOVEL STEROIDAL AROMATASE INHIBITOR, IN POSTMENOPAUSAL BREAST-CANCER PATIENTS - A PHASE-I STUDY, Clinical cancer research, 3(7), 1997, pp. 1101-1108
Authors:
GEISLER J
LIEN EA
EKSE D
LONNING PE
Citation: J. Geisler et al., INFLUENCE OF AMINOGLUTETHIMIDE ON PLASMA-LEVELS OF ESTRONE SULFATE AND DEHYDROEPIANDROSTERONE-SULFATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of steroid biochemistry and molecular biology, 63(1-3), 1997, pp. 53-58
Authors:
LONNING PE
PARIDAENS R
THURLIMANN B
PISCITELLI G
DISALLE E
Citation: Pe. Lonning et al., EXEMESTANE EXPERIENCE IN BREAST-CANCER-TREATMENT, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 151-155
Authors:
LONNING PE
GEISLER J
JOHANNESSEN DC
EKSE D
Citation: Pe. Lonning et al., PLASMA ESTROGEN SUPPRESSION WITH AROMATASE INHIBITORS EVALUATED BY A NOVEL, SENSITIVE ASSAY FOR ESTRONE SULFATE, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 255-260
Authors:
LIEN EA
ANKER G
LONNING PE
REFSUM H
UELAND PM
Citation: Ea. Lien et al., EFFECTS OF HORMONES ON THE PLASMA-LEVELS OF THE ATHEROGENIC AMINO-ACID HOMOCYSTEINE, Biochemical Society transactions, 25(1), 1997, pp. 33-35
Authors:
DOWSETT M
LONNING PE
Citation: M. Dowsett et Pe. Lonning, ANASTROZOLE - A NEW-GENERATION IN AROMATASE INHIBITION - CLINICAL-PHARMACOLOGY, Oncology, 54, 1997, pp. 11-14
Authors:
GEISLER J
ENGELSEN BA
BERNTSEN H
GEISLER S
LONNING PE
Citation: J. Geisler et al., DIFFERENTIAL EFFECT OF CARBAMAZEPINE AND VALPROATE MONOTHERAPY ON PLASMA-LEVELS OF ESTRONE SULFATE AND DEHYDROEPIANDROSTERONE-SULFATE IN MALE EPILEPTIC PATIENTS, Journal of Endocrinology, 153(2), 1997, pp. 307-312
Authors:
PAULSEN T
AAS T
BORRESEN AL
VARHAUG JE
LONNING PE
AKSLEN LA
Citation: T. Paulsen et al., ANGIOGENESIS DOES NOT PREDICT CLINICAL-RESPONSE TO DOXORUBICIN MONOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, International journal of cancer, 74(1), 1997, pp. 138-140
Authors:
ELLIS PA
LONNING PE
BORRESENDALE A
AAS T
GEISLER S
AKSLEN LA
SALTER I
SMITH IE
DOWSETT M
Citation: Pa. Ellis et al., ABSENCE OF P21 EXPRESSION IS ASSOCIATED WITH ABNORMAL P53 IN HUMAN BREAST CARCINOMAS, British Journal of Cancer, 76(4), 1997, pp. 480-485
Authors:
AAS T
BORRESEN AL
GEISLER S
SMITHSORENSEN B
JOHNSEN H
VARHAUG JE
AKSLEN LA
LONNING PE
Citation: T. Aas et al., SPECIFIC P53 MUTATIONS ARE ASSOCIATED WITH DE-NOVO RESISTANCE TO DOXORUBICIN IN BREAST-CANCER PATIENTS, Nature medicine, 2(7), 1996, pp. 811-814
Authors:
LUNDGREN S
HELLE SI
LONNING PE
Citation: S. Lundgren et al., PROFOUND SUPPRESSION OF PLASMA ESTROGENS BY MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Clinical cancer research, 2(9), 1996, pp. 1515-1521
Authors:
LONNING PE
Citation: Pe. Lonning, PHARMACOLOGY OF NEW AROMATASE INHIBITORS, Breast, 5(3), 1996, pp. 202-208